Trupanion, Inc. (NASDAQ:TRUP – Get Free Report) COO John Gallagher sold 3,603 shares of Trupanion stock in a transaction dated Thursday, May 28th. The shares were sold at an average price of $21.69, for a total value of $78,149.07. Following the transaction, the chief operating officer owned 33,065 shares in the company, valued at $717,179.85. This trade represents a 9.83% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.
Trupanion Stock Up 2.0%
Shares of NASDAQ:TRUP traded up $0.44 during trading on Monday, hitting $22.26. 403,304 shares of the company’s stock traded hands, compared to its average volume of 383,093. Trupanion, Inc. has a 52 week low of $21.16 and a 52 week high of $57.88. The company has a current ratio of 1.73, a quick ratio of 1.73 and a debt-to-equity ratio of 0.25. The company has a market cap of $970.98 million, a price-to-earnings ratio of 37.73 and a beta of 1.45. The company has a 50-day moving average price of $24.86 and a 200-day moving average price of $30.16.
Trupanion (NASDAQ:TRUP – Get Free Report) last posted its earnings results on Thursday, April 30th. The financial services provider reported $0.11 earnings per share for the quarter, topping analysts’ consensus estimates of $0.07 by $0.04. The business had revenue of $384.05 million for the quarter, compared to analyst estimates of $379.77 million. Trupanion had a return on equity of 6.87% and a net margin of 1.74%.The firm’s revenue was up 12.3% compared to the same quarter last year. During the same period in the previous year, the firm earned ($0.03) EPS. As a group, research analysts forecast that Trupanion, Inc. will post 0.53 EPS for the current fiscal year.
Hedge Funds Weigh In On Trupanion
Wall Street Analysts Forecast Growth
TRUP has been the subject of several recent research reports. Weiss Ratings downgraded Trupanion from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Wednesday, March 4th. Zacks Research downgraded Trupanion from a “strong-buy” rating to a “hold” rating in a research note on Friday, February 13th. Piper Sandler reduced their price target on Trupanion from $60.00 to $45.00 and set an “overweight” rating for the company in a research note on Friday, February 13th. Stifel Nicolaus reduced their price target on Trupanion from $35.00 to $31.00 and set a “hold” rating for the company in a research note on Tuesday, March 31st. Finally, Bank of America reduced their price target on Trupanion from $63.00 to $59.00 and set a “buy” rating for the company in a research note on Tuesday, April 14th. Two analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $42.25.
Read Our Latest Stock Report on TRUP
Trupanion Company Profile
Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.
Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.
Featured Articles
- Five stocks we like better than Trupanion
- Why These Three Big Buybacks Are Sending Very Different Signals to Investors
- Drone Stocks Soar As Pentagon Considers Funding, Including a Trump-Linked Name
- Braze Blazes Ahead on Q1 2027 Earnings Beat, Raised Guidance
- Are the 3 Newest Members of the $1 Trillion Market Cap Club the Latest Sign of an AI Bubble?
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.
